| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1606 | 2010 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 608 | 2017 |
| Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ... Annals of the rheumatic diseases 74 (6), 1188-1194, 2015 | 497 | 2015 |
| The pathophysiology of osteoarthritis F Iannone, G Lapadula Aging clinical and experimental research 15, 364-372, 2003 | 294 | 2003 |
| Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study M Elhai, M Boubaya, O Distler, V Smith, M Matucci-Cerinic, JJA Sancho, ... Annals of the rheumatic diseases 78 (7), 979-987, 2019 | 220 | 2019 |
| Increased expression of nerve growth factor (NGF) and high affinity NGF receptor (p140 TrkA) in human osteoarthritic chondrocytes F Iannone, C De Bari, F Dell'Accio, M Covelli, V Patella, G Lo Bianco, ... Rheumatology 41 (12), 1413-1418, 2002 | 206 | 2002 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 200 | 2012 |
| Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers LK Mercer, J Askling, P Raaschou, WG Dixon, L Dreyer, ML Hetland, ... Annals of the rheumatic diseases 76 (2), 386-391, 2017 | 198 | 2017 |
| Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo, F Franceschini, ... Medicine 94 (32), e1144, 2015 | 197 | 2015 |
| Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice F Cantini, C Nannini, L Niccoli, F Iannone, G Delogu, G Garlaschi, ... Autoimmunity reviews 14 (6), 503-509, 2015 | 189 | 2015 |
| MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis G Giannelli, R Erriquez, F Iannone, F Marinosci, G Lapadula, S Antonaci Clinical and experimental rheumatology 22 (3), 335-338, 2004 | 187 | 2004 |
| Digital ulcers predict a worse disease course in patients with systemic sclerosis C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ... Annals of the rheumatic diseases 75 (4), 681-686, 2016 | 185 | 2016 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 182 | 2019 |
| Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ... Annals of the rheumatic diseases 75 (1), 103-109, 2016 | 167 | 2016 |
| Obesity and inflammation-targets for OA therapy F Iannone, G Lapadula Current drug targets 11 (5), 586-598, 2010 | 158 | 2010 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 148 | 2016 |
| Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, G Lopalco, L Vannozzi, S Guerriero, ... Clinical rheumatology 36, 191-197, 2017 | 145 | 2017 |
| Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study M Imazio, A Andreis, GM De Ferrari, PC Cremer, V Mardigyan, ... European journal of preventive cardiology 27 (9), 956-964, 2020 | 141 | 2020 |
| Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ... The Journal of rheumatology 39 (6), 1179-1184, 2012 | 139 | 2012 |
| Laser-evoked potentials habituation in fibromyalgia M de Tommaso, A Federici, R Santostasi, R Calabrese, E Vecchio, ... The journal of pain 12 (1), 116-124, 2011 | 138 | 2011 |
